<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15551">Prostaglandins E2</z:chebi>, F2 alpha, 6 oxo F1 alpha and <z:chebi fb="0" ids="28728">thromboxane B2</z:chebi> increased in cisternal CSF following mock <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> in dogs, particularly <z:chebi fb="0" ids="15551">PGE2</z:chebi> (X25.5) </plain></SENT>
<SENT sid="1" pm="."><plain>Concentrations were increased also in lumbar CSF of five patients some 8 days after <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002138'>Subarachnoid haemorrhage</z:hpo> did not alter the production of <z:chebi fb="11" ids="26333">prostaglandins</z:chebi> by dog whole cortex or choroid plexuses in vitro, but production by pooled dissected cerebral arteries of <z:chebi fb="0" ids="15551">PGE2</z:chebi> was increased and of 6 oxo F1 alpha was decreased </plain></SENT>
<SENT sid="3" pm="."><plain>Intravenous <z:chebi fb="0" ids="49662">indomethacin</z:chebi> decreased <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> production by cerebral tissues, and caused a marked decrease in the prostacyclin metabolite in CSF </plain></SENT>
<SENT sid="4" pm="."><plain>The implications of our findings for the aetiology of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> are discussed </plain></SENT>
</text></document>